A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer

Clinical trial NCT04702737 · COMPLETED

Trial details

NCT number: NCT04702737
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Neuroendocrine Prostate Cancer

Start date: 2021-06-10
Primary completion: 2024-07-22
Enrollment: 41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.